
Basilea Pharmaceutica Investor Relations Material
Latest events

H2 2024
Basilea Pharmaceutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Basilea Pharmaceutica AG
Access all reports
Basilea Pharmaceutica AG is a biopharmaceutical company specializing in the research, development, and commercialization of hospital anti-infectives and oncology medicines. It focuses on therapies addressing antimicrobial resistance and cancer. The company is headquartered in Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Basilea Pharmaceutica AG


H2 2024
Basilea Pharmaceutica AG


H1 2024
Basilea Pharmaceutica AG
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
BSLN
Country
🇨🇭 Switzerland